InnoCare Pharma Ltd

FRA:33C (China)  
€ 0.55 (0%) Mar 27
At Loss
P/B:
1.01
Market Cap:
€ 1.14B ($ 1.23B)
Enterprise V:
€ 191.70M ($ 206.82M)
Volume:
-
Avg Vol (2M):
2.60K
Also Trade In:

Business Description

Description
InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.
Name Current Vs Industry Vs History
Cash-To-Debt 6.75
Equity-to-Asset 0.73
Debt-to-Equity 0.17
Debt-to-EBITDA -2.89
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.01
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.28
9-Day RSI 33.94
14-Day RSI 36.39
6-1 Month Momentum % -20.39
12-1 Month Momentum % -42.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.39
Quick Ratio 4.34
Cash Ratio 4.19
Days Inventory 349.36
Days Sales Outstanding 142.45
Days Payable 616.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.1
Shareholder Yield % 8.3

Financials (Next Earnings Date:2024-03-28 Est.)

FRA:33C's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

InnoCare Pharma Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 45.405
EPS (TTM) (€) -0.041
Beta 0.47
Volatility % 37.94
14-Day RSI 36.39
14-Day ATR (€) 0.012163
20-Day SMA (€) 0.57925
12-1 Month Momentum % -42.92
52-Week Range (€) 0.55 - 1.18
Shares Outstanding (Mil) 1,760.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

InnoCare Pharma Ltd Filings

Filing Date Document Date Form
No Filing Data

InnoCare Pharma Ltd Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

InnoCare Pharma Ltd Frequently Asked Questions

What is InnoCare Pharma Ltd(FRA:33C)'s stock price today?
The current price of FRA:33C is €0.55. The 52 week high of FRA:33C is €1.18 and 52 week low is €0.55.
When is next earnings date of InnoCare Pharma Ltd(FRA:33C)?
The next earnings date of InnoCare Pharma Ltd(FRA:33C) is 2024-03-28 Est..
Does InnoCare Pharma Ltd(FRA:33C) pay dividends? If so, how much?
InnoCare Pharma Ltd(FRA:33C) does not pay dividend.

Press Release

Subject Date
No Press Release